中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2008年
9期
886-890
,共5页
吕瑞妍%杨炼红%沈庆煜%李梅%黎祥喷%彭英
呂瑞妍%楊煉紅%瀋慶煜%李梅%黎祥噴%彭英
려서연%양련홍%침경욱%리매%려상분%팽영
脑梗死%腺病毒介导%激肽释放酶%细胞凋亡%凋亡因子
腦梗死%腺病毒介導%激肽釋放酶%細胞凋亡%凋亡因子
뇌경사%선병독개도%격태석방매%세포조망%조망인자
Cerebral infarction%Adenovirus mediated%Kallikrein%Apoptosis%Apoptotic factor
目的 探讨激肽释放酶(kallikrein)对脑梗死周边区域缺血神经细胞凋亡的作用.方法 建立大鼠大脑中动脉闭塞(MCAO)模型,将造模成功的30只大鼠采用随机数字表法分为以下几组:A组,空白对照组;B组,注射生理盐水;C组,注射pAdCMV-人类组织激肽释放酶(HTK):每组10只.观察每组大鼠处理前后神经功能损害评分(NSS),用免疫组化技术检测外源性HTK的表达,并通过TUNEL染色、RT-PCR检测细胞凋亡及凋亡因子bcl-2、bax、caspase-3 mRNA水平.结果 治疗后24h在C组中可见HTK表达阳性细胞并逐渐增多,72h后达高峰.与B组以及A组相比差异有统计学意义(112±6.1、68±4.2、59±3.9,P<0.05).治疗后72h,C组大鼠NSS神经功能评分明显低于B组以及A组(6.70±0.16、8.13±0.16、7.93±0.20,P<0.05);治疗后7 d差异更明显(5.14±0.18、7.82±0.14、7.91±0.10,P<0.01).凋亡神经细胞集中于梗死周边区,治疗后72h及7d时,C组平均TUNEL阳性细胞数较B组与A组明显减少(72 h:10.1±0.9、16.7±1.1、20.4±0.8;7 d:15.2±1.2、33.6±1.3、28.8±1.7,P<0.05).与B、A组比较,C组中bc1.2 mRNA水平增高不明显(P>0.05);治疗后72 h及7 d,bax与caspase.3 mRNA水平则明显降低(P<0.05). 结论 Kallikrein可能通过减少凋亡因子bax、caspase-3的表达,抑制脑梗死周边区域的神经细胞凋亡,从而达到保护缺血神经细胞,改善神经功能的作用.
目的 探討激肽釋放酶(kallikrein)對腦梗死週邊區域缺血神經細胞凋亡的作用.方法 建立大鼠大腦中動脈閉塞(MCAO)模型,將造模成功的30隻大鼠採用隨機數字錶法分為以下幾組:A組,空白對照組;B組,註射生理鹽水;C組,註射pAdCMV-人類組織激肽釋放酶(HTK):每組10隻.觀察每組大鼠處理前後神經功能損害評分(NSS),用免疫組化技術檢測外源性HTK的錶達,併通過TUNEL染色、RT-PCR檢測細胞凋亡及凋亡因子bcl-2、bax、caspase-3 mRNA水平.結果 治療後24h在C組中可見HTK錶達暘性細胞併逐漸增多,72h後達高峰.與B組以及A組相比差異有統計學意義(112±6.1、68±4.2、59±3.9,P<0.05).治療後72h,C組大鼠NSS神經功能評分明顯低于B組以及A組(6.70±0.16、8.13±0.16、7.93±0.20,P<0.05);治療後7 d差異更明顯(5.14±0.18、7.82±0.14、7.91±0.10,P<0.01).凋亡神經細胞集中于梗死週邊區,治療後72h及7d時,C組平均TUNEL暘性細胞數較B組與A組明顯減少(72 h:10.1±0.9、16.7±1.1、20.4±0.8;7 d:15.2±1.2、33.6±1.3、28.8±1.7,P<0.05).與B、A組比較,C組中bc1.2 mRNA水平增高不明顯(P>0.05);治療後72 h及7 d,bax與caspase.3 mRNA水平則明顯降低(P<0.05). 結論 Kallikrein可能通過減少凋亡因子bax、caspase-3的錶達,抑製腦梗死週邊區域的神經細胞凋亡,從而達到保護缺血神經細胞,改善神經功能的作用.
목적 탐토격태석방매(kallikrein)대뇌경사주변구역결혈신경세포조망적작용.방법 건립대서대뇌중동맥폐새(MCAO)모형,장조모성공적30지대서채용수궤수자표법분위이하궤조:A조,공백대조조;B조,주사생리염수;C조,주사pAdCMV-인류조직격태석방매(HTK):매조10지.관찰매조대서처리전후신경공능손해평분(NSS),용면역조화기술검측외원성HTK적표체,병통과TUNEL염색、RT-PCR검측세포조망급조망인자bcl-2、bax、caspase-3 mRNA수평.결과 치료후24h재C조중가견HTK표체양성세포병축점증다,72h후체고봉.여B조이급A조상비차이유통계학의의(112±6.1、68±4.2、59±3.9,P<0.05).치료후72h,C조대서NSS신경공능평분명현저우B조이급A조(6.70±0.16、8.13±0.16、7.93±0.20,P<0.05);치료후7 d차이경명현(5.14±0.18、7.82±0.14、7.91±0.10,P<0.01).조망신경세포집중우경사주변구,치료후72h급7d시,C조평균TUNEL양성세포수교B조여A조명현감소(72 h:10.1±0.9、16.7±1.1、20.4±0.8;7 d:15.2±1.2、33.6±1.3、28.8±1.7,P<0.05).여B、A조비교,C조중bc1.2 mRNA수평증고불명현(P>0.05);치료후72 h급7 d,bax여caspase.3 mRNA수평칙명현강저(P<0.05). 결론 Kallikrein가능통과감소조망인자bax、caspase-3적표체,억제뇌경사주변구역적신경세포조망,종이체도보호결혈신경세포,개선신경공능적작용.
Objective To investigate the effect of exogenous kallikrein on apoptosis of the neurons aroundthe cerebralinfarctareain rats. Methods Thirty rats wjth cerebral infarction induced by middle cerebral artery occlusion(MCAO)were assigned randomly into 3 groups(n=10),namely the blank control group,saline group,and pAdCMV-HTK group.In the pAdCMV-HTK group,kallikrein gene was delivered into the cerebral ischemie lesion via a replication-defective adenovims using stereotaetic injection technique, and the expression of exogenous kallikrein was detected immunohistoehemically.TUNEL staining was performed to evaluate the neuronal apoptosis around the infarct area,and RT-PCR used to detect the mRNA expressions ofbcl-2,bax and caspase-3 in the brain tissues. Results At 24 h aftertreatment there were some HTK expressed cells found in group C and peal(at 72 h after treatment.While compare with group B and group C,there existed significant difference(112±6.1,68±4.2,59±3.9,P<0.05).At 72 h after treatment,the NSS of group C was significantly lower than that ofgruop B and A(6.70±0.16,8.13±0.16,7.93±0.20,P<0.05);7 days after the treatment,the difference was more significant(5.14±0.18,7.82±0.14,7.91±0.10,P<0.01).Apoptotic cells were mostly seen around the infarct area.The ratsinpAdCMV-HTK group showed significantly reduced number of cells positive for TUNEL staining as compared to those in the saline and blank control groups at 3 days(10.1±0.9,16.7±1.1,and 20.4±0.8,respectively)and 7 days after the treatment(15.2±1.2,33.6±1.3,and 28.8±1.7,respectively)(P<0.05).The mRNA levels ofbc1-2.bax and caspasc-3 were elevated in all the groups at 24 h,peaked at 72 h,and decreased gradually till 7 days alter the treatment.Compared with those in the other two groups,bcl-2 mRNA level in the pAdCMV-HTK group increased slightly P>0.05) while bax and caspase-3 mRNA levels decreased markedly(P<0.05) 72 h and 7 days after the treatment.Conclusion Kallikrein can inhibit neuronal apoptosis around the cerebral infarct and improve the neurological fimction of rats following cerebral infarction probably by reducing the expressions of such apoptotic factors as bax and caspase-3.